FGF2 and metastatic malignant neoplasm: In Lapointe prostate cancer dataset, FGF2 expression had no statistically significant between metastatic cancer and primary PCa tissues (-0.91190 ± 0.62090 vs. 0.57764 ± 0.35019, P = 0 .174).